References
- Ngonga FG, Ferrari D, Lorusso L, Gasparetto C, Neznama E, D'Abramo M, et al. Paraneoplastic syndromes: pathogenetic theories, clinical aspects and therapeutic approach. Ann Ital Med Int 2005; 20: 28–38
- Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 1996; 14: 216–22
- Yatura S, Harrara E, Nopajaroonsri C, Singal R, Gill S. Gynaecomastia attributable to human chorionic gonadotrophin-secreting giant cell carcinoma of lung. Endocr Pract 2003; 9: 233–5
- Shah VM, Newman J, Crocker J, Antonakopoulos GN, Chapple CR, Collard MJ. Production of beta-human chorionic gonadotropin by prostatic adenocarcinoma and transitional cell carcinoma of the upper urinary tract. Br J Exp Pathol 1987; 68: 871–8
- Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H, Stenman U-H. The free β-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br J Cancer 2002; 86: 185–9
- Shimomura T, Ikemoto I, Yamada H, Hayashi N, Ito H, Oishi Y. Sarcomatoid renal cell carcinoma with a chromophobe component producing beta-human chorionic gonadotropin. Int J Urol. 2005; 12: 835–7
- Stanisic TH, Donovan J. Prolactin secreting renal cell carcinoma. J Urol 1986; 136: 85–6
- Iles RK. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumour cell apoptosis. Mol Cell Endocrinol 2007; 260: 264–70